Drug-induced Cholelithiasis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F21%3A10418885" target="_blank" >RIV/00216208:11130/21:10418885 - isvavai.cz</a>
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=JcLx0s0IKy" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=JcLx0s0IKy</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/1574884715666201217125009" target="_blank" >10.2174/1574884715666201217125009</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Drug-induced Cholelithiasis
Popis výsledku v původním jazyce
BACKGROUND: The prevalence of cholelithiasis in developed countries is high and its cause multifactorial, with a negligible proportion of drug-induced cholelithiasis. METHODS: Relevant studies were identified by PubMed, Google Scholar and Science Direct. Reference lists of retrieved articles were also reviewed. The most relevant and up-to-date information was incorporated. RESULTS: There is a wide range of drugs that can induce lithiasis. While the risk of developing lithiasis is high with some drugs (ceftriaxone, atazanavir, somatostatin analogues), it is lower or even questionable with others. Some drugs precipitate in the bile and may account for up to 100% of weight of the stone. CONCLUSION: Cholelithiasis can be induced by a wide range of drugs with different mechanisms of action.The aim of the article is to draw attention to this lesser known fact and the need to take into account the risk of developing lithiasis prior to therapy initiation.
Název v anglickém jazyce
Drug-induced Cholelithiasis
Popis výsledku anglicky
BACKGROUND: The prevalence of cholelithiasis in developed countries is high and its cause multifactorial, with a negligible proportion of drug-induced cholelithiasis. METHODS: Relevant studies were identified by PubMed, Google Scholar and Science Direct. Reference lists of retrieved articles were also reviewed. The most relevant and up-to-date information was incorporated. RESULTS: There is a wide range of drugs that can induce lithiasis. While the risk of developing lithiasis is high with some drugs (ceftriaxone, atazanavir, somatostatin analogues), it is lower or even questionable with others. Some drugs precipitate in the bile and may account for up to 100% of weight of the stone. CONCLUSION: Cholelithiasis can be induced by a wide range of drugs with different mechanisms of action.The aim of the article is to draw attention to this lesser known fact and the need to take into account the risk of developing lithiasis prior to therapy initiation.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30104 - Pharmacology and pharmacy
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Current Clinical Pharmacology
ISSN
1574-8847
e-ISSN
—
Svazek periodika
16
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
6
Strana od-do
300-305
Kód UT WoS článku
000735628900002
EID výsledku v databázi Scopus
2-s2.0-85119967520